Effectiveness and Safety of Firmagon in Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma in Argentina
Phase of Trial: Phase IV
Latest Information Update: 29 Oct 2018
At a glance
- Drugs Degarelix (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms FAST-AR
- Sponsors Ferring Pharmaceuticals
- 22 Oct 2018 Status changed from active, no longer recruiting to completed.
- 17 Sep 2018 Planned End Date changed from 1 Aug 2018 to 1 Sep 2018.
- 17 Sep 2018 Planned primary completion date changed from 1 Aug 2018 to 1 Sep 2018.